Antithrombotic Therapy

Original Contribution

Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy

11/19/2024

The aim of this LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) registry sub-study was to investigate the safety and efficacy of left atrial appendage occlusion in patients with non-valvular...

The aim of this LOGIC (Left...

11/19/2024

Journal of Invasive Cardiology

(A) Angioscopic system evaluating surface of the atrial septal occluder (ASO): low-molecular-weight dextran is infused from the guiding catheter and the tip of the GuideLiner extension catheter during observation. (B) Neointima covering most of the 22 mm ASO 6 months post implantation. (C) Around the central part of the device, the struts were exposed with marked thrombus formation. Guidewire marked by asterisks (*) in panels B and C.

Endothelialization of an Amplatzer Septal Occluder Device 6 Months Post Implantation: Is This Enough Time? An In Vivo Angioscopic Assessment

01/28/2019

Yoshihiro J. Akashi , MD, PhD;

Yukio Sato , MD, PhD;

Masaki Izumo , MD, PhD;

Tomoo Harada , MD, PhD;

Yasuhiro Tanabe , MD, PhD;

Yuki Ishibashi , MD, PhD;

Takumi Higuma , MD, PhD;

This report evaluates endothelialization in vivo and demonstrates that 6 months of postimplantation prophylactic therapy may not provide sufficient time for adequate endothelialization.

This report evaluates...

01/28/2019

Journal of Invasive Cardiology